[Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
D000328:Adult; D001161:Arteriosclerosis / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000150:complications; D010146:Pain; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
Pouvoir hypolipémiant et action myotoxique du clofibrate en cas de syndrome néphrotique.